Jones Richard B, Robins Gerry G, Howdle Peter D
Department of Academic Medicine, St James's University Hospital, Leeds, UK.
Curr Opin Gastroenterol. 2006 Mar;22(2):117-23. doi: 10.1097/01.mog.0000208460.46395.9b.
This article primarily aims to review critically research in all aspects of celiac disease over the last year. As always, there has been a wealth of relevant papers.
The role of genetics in disease susceptibility is slowly becoming more clearly defined and a more detailed understanding of the disease processes at the molecular level is paving the way towards the development of specific targeted therapies.
Despite recent advances in our understanding of celiac disease, the gluten-free diet remains the only current viable therapy and even with advances in serological tests and markers, the duodenal biopsy remains the gold standard for diagnosis and monitoring of the response to therapy.
本文主要旨在对过去一年中乳糜泻各方面的研究进行批判性回顾。一如既往,有大量相关论文。
遗传学在疾病易感性中的作用正逐渐变得更加清晰,对分子水平疾病过程的更详细理解为特定靶向治疗的开发铺平了道路。
尽管我们对乳糜泻的理解最近有所进展,但无麸质饮食仍然是目前唯一可行的治疗方法,即使血清学检测和标志物有所进步,十二指肠活检仍是诊断和监测治疗反应的金标准。